| Typicality: | 0.250 |
| Saliency: | 0.000 |
| teva v pfizer | 2 | transitive-object |
| on january | 2 | temporal |
| federal court → dismiss → both apotex | 3 |
| negative | neutral | positive |
| 0.301 | 0.654 | 0.045 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 78.345 |